It is time to drop hydroxychloroquine from our COVID-19 armamentarium

Chloroquine (CQ) and hydroxychloroquine (HCQ) were among the first drugs repurposed for the treatment of SARS-CoV-2 infection. A few in vitro studies confirmed that both drugs exhibited dose dependent anti-SARS-CoV-2 activities. These observations and the encouraging results from early poorly conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashour, Tarek, Tleyjeh, Imad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430273/
https://www.ncbi.nlm.nih.gov/pubmed/33254507
http://dx.doi.org/10.1016/j.mehy.2020.110198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430273/
https://www.ncbi.nlm.nih.gov/pubmed/33254507
http://dx.doi.org/10.1016/j.mehy.2020.110198

Ejemplares similares